Roskrow MA - Search Results

1

Immunotherapy for Epstein-Barr virus-associated cancers.

Rooney CM, Roskrow MA, Smith CA, Brenner MK, Heslop HE. Rooney CM, et al. Among authors: roskrow ma. J Natl Cancer Inst Monogr. 1998;(23):89-93. doi: 10.1093/oxfordjournals.jncimonographs.a024180. J Natl Cancer Inst Monogr. 1998. PMID: 9709309

2

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.

Roskrow MA, Suzuki N, Gan Yj, Sixbey JW, Ng CY, Kimbrough S, Hudson M, Brenner MK, Heslop HE, Rooney CM. Roskrow MA, et al. Blood. 1998 Apr 15;91(8):2925-34. Blood. 1998. PMID: 9531603 Free article. Clinical Trial.

3

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells.

Rooney CM, Roskrow MA, Suzuki N, Ng CY, Brenner MK, Heslop H. Rooney CM, et al. Among authors: roskrow ma. Ann Oncol. 1998;9 Suppl 5:S129-32. doi: 10.1093/annonc/9.suppl_5.s129. Ann Oncol. 1998. PMID: 9926252 Clinical Trial.

4

Autoimmune disease induced by dendritic cell immunization against leukemia.

Roskrow MA, Dilloo D, Suzuki N, Zhong W, Rooney CM, Brenner MK. Roskrow MA, et al. Leuk Res. 1999 Jun;23(6):549-57. doi: 10.1016/s0145-2126(99)00045-4. Leuk Res. 1999. PMID: 10374848

5

Gene transfer for the therapy of hematologic malignancy.

Heslop HE, Roskrow M. Heslop HE, et al. Curr Opin Hematol. 1995 Nov;2(6):417-22. doi: 10.1097/00062752-199502060-00004. Curr Opin Hematol. 1995. PMID: 9372030 Review.

6

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

Roskrow MA, Rooney CM, Heslop HE, Brenner MK, Krance RA, Gresik MV, McClain K, Aguilar LK, Grilley B, Rob E, Carrum G. Roskrow MA, et al. Hum Gene Ther. 1998 May 20;9(8):1237-50. doi: 10.1089/hum.1998.9.8-1237. Hum Gene Ther. 1998. PMID: 9625264 Clinical Trial. No abstract available.

7

CD40 ligand induces an antileukemia immune response in vivo.

Dilloo D, Brown M, Roskrow M, Zhong W, Holladay M, Holden W, Brenner M. Dilloo D, et al. Blood. 1997 Sep 1;90(5):1927-33. Blood. 1997. PMID: 9292526 Free article.

8

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease.

Su Z, Peluso MV, Raffegerst SH, Schendel DJ, Roskrow MA. Su Z, et al. Among authors: roskrow ma. Eur J Immunol. 2001 Mar;31(3):947-58. doi: 10.1002/1521-4141(200103)31:3<947::aid-immu947>3.0.co;2-m. Eur J Immunol. 2001. PMID: 11241300 Free article.

9

Tumor vaccines--application to childhood cancer.

Roskrow MA, Zibert A, Souquet M, Dilloo D. Roskrow MA, et al. Klin Padiatr. 1999 Jul-Aug;211(4):336-46. doi: 10.1055/s-2008-1043811. Klin Padiatr. 1999. PMID: 10472573 Review.

10

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.

Zibert A, Thomassen A, Müller L, Nguyen L, Glouchkova L, Fraefel C, Roskrow M, Meisel R, Dilloo D. Zibert A, et al. Gene Ther. 2005 Dec;12(23):1707-17. doi: 10.1038/sj.gt.3302577. Gene Ther. 2005. PMID: 16034459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters